Comments
Loading...

National Health Investors

NHINYSE
Logo brought to you by Benzinga Data
$85.15
00.00%
Pre-Market: 4:53 PM EDT
15 minutes delayed
The dividend Ex-Date is in 8 days
Consensus Rating1
Hold
Highest Price Target1
$78.00
Lowest Price Target1
$50.00
Consensus Price Target1
$61.42

National Health Investors (NYSE:NHI) Stock, Analyst Ratings, Price Targets, Forecasts

National Health Investors Inc has a consensus price target of $61.42 based on the ratings of 13 analysts. The high is $78 issued by Truist Securities on August 30, 2024. The low is $50 issued by Credit Suisse on March 29, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Truist Securities, and Wells Fargo on August 30, 2024, June 26, 2024, and May 30, 2024, respectively. With an average price target of $70.67 between Truist Securities, Truist Securities, and Wells Fargo, there's an implied -17.01% downside for National Health Investors Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
May
0
0
0
0
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Truist Securities
Wells Fargo
Wedbush
BMO Capital
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for National Health Investors

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for National Health Investors (NHI) stock?

A

The latest price target for National Health Investors (NYSE:NHI) was reported by Truist Securities on August 30, 2024. The analyst firm set a price target for $78.00 expecting NHI to fall to within 12 months (a possible -8.40% downside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for National Health Investors (NHI)?

A

The latest analyst rating for National Health Investors (NYSE:NHI) was provided by Truist Securities, and National Health Investors maintained their hold rating.

Q

When was the last upgrade for National Health Investors (NHI)?

A

The last upgrade for National Health Investors Inc happened on March 12, 2024 when BMO Capital raised their price target to $67. BMO Capital previously had a market perform for National Health Investors Inc.

Q

When was the last downgrade for National Health Investors (NHI)?

A

The last downgrade for National Health Investors Inc happened on June 21, 2022 when BMO Capital changed their price target from N/A to $62 for National Health Investors Inc.

Q

When is the next analyst rating going to be posted or updated for National Health Investors (NHI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on August 30, 2024 so you should expect the next rating to be made available sometime around August 30, 2025.

Q

Is the Analyst Rating National Health Investors (NHI) correct?

A

While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $65.00 to $78.00. The current price National Health Investors (NHI) is trading at is $85.15, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch